106 related articles for article (PubMed ID: 38713997)
1. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
3. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
[TBL] [Abstract][Full Text] [Related]
5. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 2021 FIGO staging schema for advanced vulvar cancer.
Matsuo K; Klar M; Nishio S; Mikami M; Roman LD; Wright JD
Int J Gynecol Cancer; 2022 Apr; 32(4):474-479. PubMed ID: 34996835
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
[TBL] [Abstract][Full Text] [Related]
9. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
Cooke EW; Pappas L; Gaffney DK
Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
[TBL] [Abstract][Full Text] [Related]
10. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
[TBL] [Abstract][Full Text] [Related]
12. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system.
Kato T; Watari H; Endo D; Mitamura T; Odagiri T; Konno Y; Hosaka M; Kobayashi N; Todo Y; Sudo S; Takeda M; Dong P; Kaneuchi M; Kudo M; Sakuragi N
J Surg Oncol; 2012 Dec; 106(8):938-41. PubMed ID: 22740340
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
14. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
15. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
[TBL] [Abstract][Full Text] [Related]
16. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y; Ding J; Hua K
J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
[TBL] [Abstract][Full Text] [Related]
17. FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype.
Haltia UM; Bützow R; Leminen A; Loukovaara M
J Gynecol Oncol; 2014 Jan; 25(1):30-5. PubMed ID: 24459578
[TBL] [Abstract][Full Text] [Related]
18. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
19. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]